過去幾年的一系列收購和其他交易增強了我們在業務各個方面的領導地位,並為我們的平台增添了增長引擎。我們在2020年12月收購了Origin Laboratories, Inc.(或稱Origin),這一舉措顯著加強了我們在聚合物3d打印的量產領域中的領導地位。Origin在增材製造終端使用零件方面的開創性方法使我們能夠使用工業級3d打印機服務於一個龐大的市場,採用P3可編程光聚合技術。我們在2021年第一季度收購英國RP Support Ltd.(或稱RPS),這是一家提供工業立體光刻3d打印機及解決方案的公司,為我們提供了互補技術,進一步拓展了我們的聚合物解決方案套件,覆蓋產品生命周期。同樣,我們在2021年11月收購了Xaar 3D Ltd.(或稱Xaar)的所有剩餘股份,已開始加速我們在生產規模3d打印的增長。我們之前的子公司MakerBot(桌面3d打印的領導者)與Ultimaker之間的交易,使我們在這家擁有廣泛技術供應、規模更大並資本充足的新實體中擁有約46.5%的股份,因此能更好地在桌面3d打印領域競爭。我們在2022年10月從質量保證軟體公司Riven(位於加州伯克利的一家初創公司)收購的資產使我們能夠將其基於雲的軟體解決方案完全集成到我們的GrabCAD®增材製造平台中,從而使更多的製造客戶能夠採用stratasys的解決方案來生產終端使用零件。我們在2023年4月收購Covestro的增材製造業務,使我們能夠加速在3d打印材料方面的創新發展,並進一步增長對我們最新技術的採用,包括我們的Origin P3™、小蟻®立體光刻機和H350™打印機,可以使用Covestro的樹脂。此外,作為此次收購的一部分,我們獲得了一個由數百項專利和待審專利組成的知識產權組合。
(ii) 我們的第二項倡議是加強我們的努力,消除障礙,幫助客戶加快對增材製造的採用步伐。這涉及到總擁有成本,主要受材料消耗的影響。我們計劃增加資源投資,以更好地教育和支持我們客戶的工程師,他們仍在學習充分利用增材製造的設計和工作流程優勢。我們還將增加努力,標準化增材製造,以更好地與傳統製造流程對接,從而使其更容易被廣泛採用。作為這項倡議的一部分,我們計劃利用我們的規模和技術廣度,將市場推廣重點放在我們認為是業務主要增長動力的領域——增材製造相對於傳統方法所顯示的最具吸引力的應用。
我們當前的展望,以及截至2024年9月30日的三個月和九個月期間的業務表現,應根據當前的全球宏觀經濟條件來評估,包括某些挑戰性的趨勢,這些趨勢也影響了增材製造行業。我們在截至2024年9月30日的九個月期間的營業收入與截至2023年9月30日的相應九個月相比減少了10.4%。這一營業收入的減少主要是由於我們客戶的資本支出預算受到宏觀經濟壓力的影響,這導致了我們系統的銷售週期延長以及偶爾的系統訂單推遲。我們的業績還反映了對某些stratasys direct manufacturing(SDm)業務的剝離。另一方面,我們截至2024年9月30日的三個月和九個月期間的業績也顯示出我們的客戶對安裝系統的利用率增強,這推動了消耗品收入的增長,此外,我們在截至2024年9月30日的季度中實現了非GAAP盈利(連同我們的GAAP淨虧損),而在2024年的前兩個季度未能實現這樣的盈利(請參見“非GAAP基礎的補充經營結果” 並且“GAAP與非GAAP經營結果的調整” f更下方).
業務 expenses were $26310萬 in the nine months ended September 30, 2024, compared to operating expenses of $29050萬 in the nine months ended September 30, 2023. The decrease in operating expenses was primarily driven by lower costs related to prospective and potential mergers and acquisitions, defense against hostile tender offer, proxy contest and related professional fees, which decreased by $2270萬, $300萬 lower loss as a result of revaluation of our investment in unconsolidated entities, lower amortization expenses of $280萬 and $200萬 lower employee related expenses, partially offset by higher costs driven by our recent acquisitions and higher charges related to restructuring costs of $600萬.
Research and development expenses, net increased by 500萬美元, or 7.2%, to 截至2024年9月30日的九個月內,我們的收入為7440萬美元,而截至2023年9月30日的九個月內為6930萬美元。增長的主要因素是因近期收購導致的成本上升200萬美元和員工相關費用上升180萬美元。這些費用佔營業收入的百分比 。,構成了 17.6% 了 我們截至2024年9月30日的九個月內的營業收入,同比於截至2023年9月30日的九個月內的14.7%。
We had an effective tax rate of 3.1% for the nine months ended September 30, 2024, compared to an effective tax rate of 5.6% for the nine months ended September 30, 2023. Our effective tax rate in the nine months ended September 30, 2024 was primarily impacted by the geographic mix of our earnings and losses, movements in our valuation allowances and changes in our uncertain tax positions.
Share in Losses of Associated Companies
Share in losses of associated companies reflects our proportionate share of the losses of unconsolidated entities accounted for by using the equity method of accounting. During the nine months ended September 30, 2024, the loss from our proportionate share of the losses of our equity method investments was $160萬, compared to a loss of $1190萬 in the nine months ended September 30, 2023.
Net Loss and Net Loss Per Share
Net loss (on an absolute basis and as a percentage of revenues), and diluted net loss per share were as follows:
我們已根據美國普遍公認的會計原則編制了合併基本報表及相關披露。這要求我們做出影響報告金額的估計、判斷和假設。實際結果可能與這些估計不同。要更好地理解我們的業務活動及對於財務狀況和經營成果的呈現重要的會計政策,並且需要管理層的主觀判斷,請參見我們 2023 Annual Report. We base our judgements on our experience and various assumptions that we believe to be reasonable under the circumstances.
Forward-Looking Statements and Factors That May Affect Future Results of Operations
Certain information included in or incorporated by reference into the Report of Foreign Private Issuer on Form 6-k to which this Operating and Financial Review and Prospects is appended, or the Form 6-k, may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are those that predict or describe future events or trends and that do not relate solely to historical matters. You can generally identify forward-looking statements as statements containing the words “may,” “will,” “could,” “should,” “expect,” “anticipate,” “intend,” “estimate,” “believe,” “project,” “plan,” “assume” or other similar expressions, or negatives of those expressions, although not all forward-looking statements contain these identifying words.
These forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections of results of operations or of financial condition and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.
You should not place undue reliance on our forward-looking statements because the matters they describe are subject to certain risks, uncertainties and assumptions that are difficult to predict. Our forward-looking statements are based on the information currently available to us and speak only as of the date of the Form 6-k. Over time, our actual results, performance or achievements may differ from those expressed or implied by our forward-looking statements, and such difference might be significant and materially adverse to our shareholders. We undertake no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.